The aryl hydrocarbon receptor cross-talks with multiple signal transduction pathways

Biochemical Pharmacology

Volumn 77, Issue 4, 2009, Pages 713-722

  Puga, Alvaro ^a   Ma, Ci ^a   Marlowe, Jennifer L ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Apoptosis; Aryl hydrocarbon receptor; Cell cycle progression; Differentiation; E2F; Mitogen activated kinases; Phosphorylation; RB

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F;

APOPTOSIS; ARTICLE; CELL CYCLE REGULATION; CELL DIFFERENTIATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; XENOBIOTIC METABOLISM;

ANIMALS; APOPTOSIS; CELL CYCLE; ENVIRONMENTAL POLLUTANTS; HUMANS; RECEPTOR CROSS-TALK; RECEPTORS, ARYL HYDROCARBON; SIGNAL TRANSDUCTION; TETRACHLORODIBENZODIOXIN;

EID: 59149097969     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2008.08.031     Document Type: Article

References (100)

1. Safe S. Molecular biology of the Ah receptor and its role in carcinogenesis. Toxicol Lett 120 (2001) 1-7
2. Okey A.B. An aryl hydrocarbon receptor odyssey to the shores of toxicology: the Deichmann Lecture, International Congress of Toxicology-XI. Toxicol Sci 98 (2007) 5-38
3. Hoffman E.C., Reyes H., Chu F.-F., Sander F., Conley L.H., Brooks B.A., et al. Cloning of a factor required for activity of the Ah (dioxin) receptor. Science 252 (1991) 954-958
4. Hogenesch J.B., Chan W.K., Jackiw V., Brown R.C., Gu Y.-Z., Pray-Grant M., et al. Characterization of a subset of the basic-helix-loop-helix-PAS superfamily that interacts with components of the dioxin signaling pathway. J Biol Chem 272 (1997) 8581-8593
5. Crews S.T., and Fan C.M. Remembrance of things PAS: regulation of development by bHLH-PAS proteins. Curr Opin Genet Dev 9 (1999) 580-587
6. Barouki R., Coumoul X., and Fernandez-Salguero P.M. The aryl hydrocarbon receptor, more than a xenobiotic-interacting protein. FEBS Lett 581 (2007) 3608-3615
7. Abbott B.D., Birnbaum L.S., and Perdew G.H. Developmental expression of two members of a new class of transcription factors: I. Expression of aryl hydrocarbon receptor in the C57BL/6N mouse embryo. Dev Dynam 204 (1995) 133-143
8. Ma Q., and Whitlock Jr. J.P. A novel cytoplasmic protein that interacts with the Ah receptor, contains tetratricopeptide repeat motifs, and augments the transcriptional response to 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Biol Chem 272 (1997) 8878-8884
9. Carver L.A., and Bradfield C.A. Ligand-dependent interaction of the aryl hydrocarbon receptor with a novel immunophilin homolog in vivo. J Biol Chem 272 (1997) 11452-11456
10. Petrulis J.R., Kusnadi A., Ramadoss P., Hollingshead B., and Perdew G.H. The hsp90 Co-chaperone XAP2 alters importin beta recognition of the bipartite nuclear localization signal of the Ah receptor and represses transcriptional activity. J Biol Chem 278 (2003) 2677-2685
11. Beischlag T.V., Wang S., Rose D.W., Torchia J., Reisz-Porszasz S., Muhammad K., et al. Recruitment of the NCoA/SRC-1/p160 family of transcriptional coactivators by the aryl hydrocarbon receptor/aryl hydrocarbon receptor nuclear translocator complex. Mol Cell Biol 22 (2002) 4319-4333
12. Wang S., and Hankinson O. Functional involvement of the Brahma/SWI2-related gene 1 protein in cytochrome P4501A1 transcription mediated by the aryl hydrocarbon receptor complex. J Biol Chem 277 (2002) 11821-11827
13. Hestermann E.V., and Brown M. Agonist and chemopreventative ligands induce differential transcriptional cofactor recruitment by aryl hydrocarbon receptor. Mol Cell Biol 23 (2003) 7920-7925
14. Wang S., Ge K., Roeder R.G., and Hankinson O. Role of mediator in transcriptional activation by the aryl hydrocarbon receptor. J Biol Chem 279 (2004) 13593-13600
15. Schnekenburger M., Peng L., and Puga A. HDAC1 bound to the Cyp1a1 promoter blocks histone acetylation associated with Ah receptor-mediated trans-activation. Biochim Biophys Acta 1769 (2007) 569-578
16. Pollenz R.S. The mechanism of AH receptor protein down-regulation (degradation) and its impact on AH receptor-mediated gene regulation. Chem Biol Interact 141 (2002) 41-61
17. Puga A., Xia Y., and Elferink C. Role of the aryl hydrocarbon receptor in cell cycle regulation. Chem Biol Interact 141 (2002) 117-130
18. Henklova P., Vrzal R., Ulrichova J., and Dvorak Z. Role of mitogen-activated protein kinases in aryl hydrocarbon receptor signaling. Chem Biol Interact 172 (2008) 93-104
19. Carrier F., Owens R.A., Nebert D.W., and Puga A. Dioxin-dependent activation of murine Cyp1a-1 gene transcription requires protein kinase C-dependent phosphorylation. Mol Cell Biol 12 (1992) 1856-1863
20. Okino S.T., Pendurthi U.R., and Tukey R.H. Phorbol esters inhibit the dioxin receptor-mediated transcriptional activation of the mouse Cyp1a-1 and Cyp1a-2 genes by 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Biol Chem 267 (1992) 6991-6998
21. Ikegwuonu F.I., Christou M., and Jefcoate C.R. Regulation of cytochrome P4501B1 (CYP1B1) in mouse embryo fibroblast (C3H10T1/2) cells by protein kinase C (PKC). Biochem Pharmacol 57 (1999) 619-630
22. Pongratz I., Strömstedt P.E., Mason G.G., and Poellinger L. Inhibition of the specific DNA binding activity of the dioxin receptor by phosphatase treatment. J Biol Chem 266 (1991) 16813-16817
23. Mahon M.J., and Gasiewicz T.A. Ah receptor phosphorylation: localization of phosphorylation sites to the C-terminal half of the protein. Arch Biochem Biophys 318 (1995) 166-174
24. Chen Y.H., and Tukey R.H. Protein kinase C modulates regulation of the CYP1A1 gene by the aryl hydrocarbon receptor. J Biol Chem 271 (1996) 26261-26266
25. Long W.P., Pray-Grant M., Tsai J.C., and Perdew G.H. Protein kinase C activity is required for aryl hydrocarbon receptor pathway-mediated signal transduction. Mol Pharmacol 53 (1998) 691-700
26. Park S., Henry E.C., and Gasiewicz T.A. Regulation of DNA binding activity of the ligand-activated aryl hydrocarbon receptor by tyrosine phosphorylation. Arch Biochem Biophys 381 (2000) 302-312
27. Li S.Y., and Dougherty J.J. Inhibitors of serine/threonine-specific protein phosphatases stimulate transcription by the Ah receptor/Arnt dimer by affecting a step subsequent to XRE binding. Arch Biochem Biophys 340 (1997) 73-82
28. Dieter M.Z., Freshwater S.L., Solis W.A., Nebert D.W., and Dalton T.P. Tryphostin AG879, a tyrosine kinase inhibitor: prevention of transcriptional activation of the electrophile and the aromatic hydrocarbon response elements. Biochem Pharmacol 61 (2001) 215-225
29. Ikuta T., Kobayashi Y., and Kawajiri K. Phosphorylation of nuclear localization signal inhibits the ligand-dependent nuclear import of aryl hydrocarbon receptor. Biochem Biophys Res Commun 317 (2004) 545-550
30. Minsavage G.D., Park S.K., and Gasiewicz T.A. The aryl hydrocarbon receptor (AhR) tyrosine 9, a residue that is essential for AhR DNA binding activity, is not a phosphoresidue but augments AhR phosphorylation. J Biol Chem 279 (2004) 20582-20593
31. Pratt W.B. The role of the hsp90-based chaperone system in signal transduction by nuclear receptors and receptors signaling via MAP kinase. Annu Rev Pharmacol Toxicol 37 (1997) 297-326
32. Ogiso H., Kagi N., Matsumoto E., Nishimoto M., Arai R., Shirouzu M., et al. Phosphorylation analysis of 90 kDa heat shock protein within the cytosolic arylhydrocarbon receptor complex. Biochemistry 43 (2004) 15510-15519
33. Cobb M.H., and Goldsmith E.J. Dimerization in MAP-kinase signaling. Trends Biochem Sci 25 (2000) 7-9
34. Weston C.R., and Davis R.J. The JNK signal transduction pathway. Curr Opin Cell Biol 19 (2007) 142-149
35. Tan Z., Chang X., Puga A., and Xia Y. Activation of mitogen-activated protein kinases (MAPKs) by aromatic hydrocarbons: role in the regulation of aryl hydrocarbon receptor (AHR) function. Biochem Pharmacol 64 (2002) 771-780
36. Tan Z., Huang M., Puga A., and Xia Y. A critical role for MAP kinases in the control of Ah receptor complex activity. Toxicol Sci 82 (2004) 80-87
37. Diry M., Tomkiewicz C., Koehle C., Coumoul X., Bock K.W., Barouki R., et al. Activation of the dioxin/aryl hydrocarbon receptor (AhR) modulates cell plasticity through a JNK-dependent mechanism. Oncogene 25 (2006) 5570-5574
38. Puga A., Nebert D.W., and Carrier F. Dioxin induces expression of c-fos and c-jun proto-oncogenes and a large increase in transcription factor AP-1. DNA Cell Biol 11 (1992) 269-281
39. Hoffer A., Chang C.-Y., and Puga A. Dioxin induces fos and jun gene expression by Ah receptor dependent- and independent-pathways. Toxicol Appl Pharmacol 141 (1996) 238-247
40. Weiss C., Faust D., Durk H., Kolluri S.K., Pelzer A., Schneider S., et al. TCDD induces c-jun expression via a novel Ah (dioxin) receptor-mediated p38-MAPK-dependent pathway. Oncogene 24 (2005) 4975-4983
41. Weiss C., Faust D., Schreck I., Ruff A., Farwerck T., Melenberg A., et al. TCDD deregulates contact inhibition in rat liver oval cells via Ah receptor, JunD and cyclin A. Oncogene 27 (2008) 2198-2207
42. Ikuta T., Kobayashi Y., and Kawajiri K. Cell density regulates intracellular localization of aryl hydrocarbon receptor. J Biol Chem 279 (2004) 19209-19216
43. Park S.J., Yoon W.K., Kim H.J., Son H.Y., Cho S.W., Jeong K.S., et al. 2,3,7,8-Tetrachlorodibenzo-p-dioxin activates ERK and p38 mitogen-activated protein kinases in RAW 264.7 cells. Anticancer Res 25 (2005) 2831-2836
44. Reiners Jr. J.J., Lee J.Y., Clift R.E., Dudley D.T., and Myrand S.P. PD98059 is an equipotent antagonist of the aryl hydrocarbon receptor and inhibitor of mitogen-activated protein kinase. Mol Pharmacol 53 (1998) 438-445
45. Joiakim A., Mathieu P.A., Palermo C., Gasiewicz T.A., and Reiners Jr. J.J. The Jun N-terminal kinase inhibitor SP600125 is a ligand and antagonist of the aryl hydrocarbon receptor. Drug Metab Dispos 31 (2003) 1279-1282
46. Andrieux L., Langouet S., Fautrel A., Ezan F., Krauser J.A., Savouret J.F., et al. Aryl hydrocarbon receptor activation and cytochrome P450 1A induction by the mitogen-activated protein kinase inhibitor U0126 in hepatocytes. Mol Pharmacol 65 (2004) 934-943
47. Caruso J.A., Mathieu P.A., Joiakim A., Zhang H., and Reiners Jr. J.J. Aryl hydrocarbon receptor modulation of tumor necrosis factor-alpha-induced apoptosis and lysosomal disruption in a hepatoma model that is caspase-8-independent. J Biol Chem 281 (2006) 10954-10967
48. Dvorak Z., Vrzal R., Henklova P., Jancova P., Anzenbacherova E., Maurel P., et al. JNK inhibitor SP600125 is a partial agonist of human aryl hydrocarbon receptor and induces CYP1A1 and CYP1A2 genes in primary human hepatocytes. Biochem Pharmacol 75 (2008) 580-588
49. Shibazaki M., Takeuchi T., Ahmed S., and Kikuchi H. Suppression by p38 MAP kinase inhibitors (pyridinyl imidazole compounds) of Ah receptor target gene activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin and the possible mechanism. J Biol Chem 279 (2004) 3869-3876
50. Shibazaki M., Takeuchi T., Ahmed S., and Kikuchi H. Blockade by SB203580 of Cyp1a1 induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin, and the possible mechanism: possible involvement of the p38 mitogen-activated protein kinase pathway in shuttling of Ah receptor overexpressed in COS-7 cells. Ann NY Acad Sci 1030 (2004) 275-281
51. Ramakrishna G., Perella C., Birely L., Diwan B.A., Fornwald L.W., and Anderson L.M. Decrease in K-ras p21 and increase in Raf1 and activated Erk 1 and 2 in murine lung tumors initiated by N-nitrosodimethylamine and promoted by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Appl Pharmacol 179 (2002) 21-34
52. Lecureur V., Ferrec E.L., N'diaye M., Vee M.L., Gardyn C., Gilot D., et al. ERK-dependent induction of TNFalpha expression by the environmental contaminant benzo(a)pyrene in primary human macrophages. FEBS Lett 579 (2005) 1904-1910
53. Chen S., Operana T., Bonzo J., Nguyen N., and Tukey R.H. ERK kinase inhibition stabilizes the aryl hydrocarbon receptor: implications for transcriptional activation and protein degradation. J Biol Chem 280 (2005) 4350-4359
54. Yim S., Oh M., Choi S.M., and Park H. Inhibition of the MEK-1/p42 MAP kinase reduces aryl hydrocarbon receptor-DNA interactions. Biochem Biophys Res Commun 322 (2004) 9-16
55. Cheng M., Olivier P., Diehl J.A., Fero M., Roussel M.F., Roberts J.M., et al. The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J 18 (1999) 1571-1583
56. Sherr C.J., and Roberts J.M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13 (1999) 1501-1512
57. Smits V.A., and Medema R.H. Checking out the G(2)/M transition. Biochim Biophys Acta 1519 (2001) 1-12
58. Weiss C., Kolluri S.K., Kiefer F., and Gottlicher M. Complementation of Ah receptor deficiency in hepatoma cells: negative feedback regulation and cell cycle control by the Ah receptor. Exp Cell Res 226 (1996) 154-163
59. Ma Q., and Whitlock J.P.J. The aromatic hydrocarbon receptor modulates the Hepa 1c1c7 cell cycle and differentiated state independently of dioxin. Mol Cell Biol 16 (1996) 2144-2150
60. Ge N.-L., and Elferink C.J. A direct interaction between the aryl hydrocarbon receptor and retinoblatoma protein. J Biol Chem 273 (1998) 22708-22713
61. Kolluri S.K., Weiss C., Koff A., and Göttlicher M. p27kip1 induction and inhibition of proliferation by the intracellular Ah receptor in developing thymus and hepatoma cells. Genes Dev 13 (1999) 1742-1753
62. Puga A., Barnes S.J., Dalton T.P., Chang C., Knudsen E.S., and Maier M.A. Aromatic hydrocarbon receptor interaction with the retinoblastoma protein potentiates repression of E2F-dependent transcription and cell cycle arrest. J Biol Chem 275 (2000) 2943-2950
63. Elferink C.J., Ge N.L., and Levine A. Maximal aryl hydrocarbon receptor activity depends on an interaction with the retinoblastoma protein. Mol Pharmacol 59 (2001) 664-673
64. Elizondo G., Fernandez-Salguero P., Sheikh M.S., Kim G.Y., Fornace A.J., Lee K.S., et al. Altered cell cycle control at the G(2)/M phases in aryl hydrocarbon receptor-null embryo fibroblast. Mol Pharmacol 57 (2000) 1056-1063
65. Tohkin M., Fukuhara M., Elizondo G., Tomita S., and Gonzalez F.J. Aryl hydrocarbon receptor is required for p300-mediated induction of DNA synthesis by adenovirus E1A. Mol Pharmacol 58 (2000) 845-851
66. Gierthy J.F., and Crane D. Reversible inhibition of in vitro epithelial cell proliferation by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Appl Pharmacol 74 (1984) 91-98
67. Hushka D.R., and Greenlee W.F. 2,3,7,8-Tetrachlorodibenzo-p-dioxin inhibits DNA synthesis in rat primary hepatocytes. Mutat Res 333 (1995) 89-99
68. Bauman J.W., Goldsworthy T.L., Dunn C.S., and Fox T.R. Inhibitory effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on rat hepatocyte proliferation induced by 2/3 partial hepatectomy. Cell Prolif 28 (1995) 437-451
69. Marlowe J.L., and Puga A. Aryl hydrocarbon receptor, cell cycle regulation, toxicity, and tumorigenesis. J Cell Biochem 96 (2005) 1174-1184
70. Chan H.M., Smith L., and La Thangue N.B. Role of LXCXE motif-dependent interactions in the activity of the retinoblastoma protein. Oncogene 20 (2001) 6152-6163
71. Strobeck M.W., Fribourg A.F., Puga A., and Knudsen E.S. Restoration of retinoblastoma mediated signaling to Cdk2 results in cell cycle arrest. Oncogene 19 (2000) 1857-1867
72. Marlowe J.L., Knudsen E.S., Schwemberger S., and Puga A. The aryl hydrocarbon receptor displaces p300 from E2F-dependent promoters and represses S-phase specific gene expression. J Biol Chem 279 (2004) 29013-29022
73. Huang G., and Elferink C.J. Multiple mechanisms are involved in Ah receptor-mediated cell cycle arrest. Mol Pharmacol 67 (2005) 88-96
74. Andrysik Z., Vondracek J., Machala M., Krcmar P., Svihalkova-Sindlerova L., Kranz A., et al. The aryl hydrocarbon receptor-dependent deregulation of cell cycle control induced by polycyclic aromatic hydrocarbons in rat liver epithelial cells. Mutat Res 615 (2007) 87-97
75. Currier N., Solomon S.E., Demicco E.G., Chang D.L., Farago M., Ying H., et al. Oncogenic signaling pathways activated in DMBA-induced mouse mammary tumors. Toxicol Pathol 33 (2005) 726-737
76. Peng L., Mayhew C.N., Schnekenburger M., Knudsen E.S., and Puga A. Repression of Ah receptor and induction of transforming growth factor-beta genes in DEN-induced mouse liver tumors. Toxicology 246 (2008) 242-247
77. Mulero-Navarro S., Carvajal-Gonzalez J.M., Herranz M., Ballestar E., Fraga M.F., Ropero S., et al. The dioxin receptor is silenced by promoter hypermethylation in human acute lymphoblastic leukemia through inhibition of Sp1 binding. Carcinogenesis 27 (2006) 1099-1104
78. Barnes-Ellerbe S., Knudsen K.E., and Puga A. 2,3,7,8-Tetrachlorodibenzo-p-dioxin blocks androgen-dependent cell proliferation of LNCaP cells through modulation of pRB phosphorylation. Mol Pharmacol 66 (2004) 502-511
79. Chang X., Fan Y., Karyala S., Schwemberger S., Tomlinson C.R., Sartor M.A., et al. Ligand-independent regulation of transforming growth factor beta1 expression and cell cycle progression by the aryl hydrocarbon receptor. Mol Cell Biol 27 (2007) 6127-6139
80. Roberts R.A., Nebert D.W., Hickman J.A., Richburg J.H., and Goldsworthy T.L. Perturbation of the mitosis/apoptosis balance: a fundamental mechanism in toxicology. Fund Appl Toxicol 38 (1997) 107-115
81. Schwarz M., Buchmann A., Stinchcombe S., Kalkuhl A., and Bock K. Ah receptor ligands and tumor promotion: survival of neoplastic cells. Toxicol Lett 112-113 (2000) 69-77
82. Bock K.W., and Kohle C. Ah receptor- and TCDD-mediated liver tumor promotion: clonal selection and expansion of cells evading growth arrest and apoptosis. Biochem Pharmacol 69 (2005) 1403-1408
83. 2+-mediated endonuclease activation. Science 242 (1988) 256-259
84. Kurl R.N., Abraham M., and Olnes M.J. Early effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on rat thymocytes in vitro. Toxicology 77 (1993) 103-114
85. Silverstone A.E., Frazier Jr. D.E., and Gasiewicz T.A. Alternate immune system targets for TCDD: lymphocyte stem cells and extrathymic T-cell development. Exp Clin Immunogenet 11 (1994) 94-101
86. Nebert D.W., Roe A.L., Dieter M.Z., Solis W.A., Yang Y., and Dalton T.P. Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis. Biochem Pharmacol 59 (2000) 65-85
87. Chen S., Nguyen N., Tamura K., Karin M., and Tukey R.H. The role of the Ah receptor and p38 in benzo[a]pyrene-7,8-dihydrodiol and benzo[a]pyrene-7,8-dihydrodiol-9,10-epoxide-induced apoptosis. J Biol Chem 278 (2003) 19526-19533
88. Schlezinger J.J., Liu D., Farago M., Seldin D.C., Belguise K., Sonenshein G.E., et al. A role for the aryl hydrocarbon receptor in mammary gland tumorigenesis. Biol Chem 387 (2006) 1175-1187
89. Gonzalez F.J., and Fernandez-Salguero P. The aryl hydrocarbon receptor: studies using the AHR-null mice. Drug Metab Dispos 26 (1998) 1194-1198
90. Viluksela M., Bager Y., Tuomisto J.T., Scheu G., Unkila M., Pohjanvirta R., et al. Liver tumor-promoting activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in TCDD-sensitive and TCDD-resistant rat strains. Cancer Res 60 (2000) 6911-6920
91. Paajarvi G., Viluksela M., Pohjanvirta R., Stenius U., and Hogberg J. TCDD activates Mdm2 and attenuates the p53 response to DNA damaging agents. Carcinogenesis 26 (2005) 201-208
92. Vogel C.F., Li W., Sciullo E., Newman J., Hammock B., Reader J.R., et al. Pathogenesis of aryl hydrocarbon receptor-mediated development of lymphoma is associated with increased cyclooxygenase-2 expression. Am J Pathol 171 (2007) 1538-1548
93. Wu R., Zhang L., Hoagland M.S., and Swanson H.I. Lack of the aryl hydrocarbon receptor leads to impaired activation of AKT/protein kinase B and enhanced sensitivity to apoptosis induced via the intrinsic pathway. J Pharmacol Exp Ther 320 (2007) 448-457
94. Sarioglu H., Brandner S., Haberger M., Jacobsen C., Lichtmannegger J., Wormke M., et al. Analysis of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced proteome changes in 5L rat hepatoma cells reveals novel targets of dioxin action including the mitochondrial apoptosis regulator VDAC2. Mol Cell Proteomics 7 (2008) 394-410
95. Coutts S.M., Fulton N., and Anderson R.A. Environmental toxicant-induced germ cell apoptosis in the human fetal testis. Hum Reprod 22 (2007) 2912-2918
96. Worner W., and Schrenk D. Influence of liver tumor promoters on apoptosis in rat hepatocytes induced by 2-acetylaminofluorene, ultraviolet light, or transforming growth factor beta 1. Cancer Res 56 (1996) 1272-1278
97. Schrenk D., Schmitz H.J., Bohnenberger S., Wagner B., and Worner W. Tumor promoters as inhibitors of apoptosis in rat hepatocytes. Toxicol Lett 149 (2004) 43-50
98. Trimarchi J.M., and Lees J.A. Sibling rivalry in the E2F family. Nat Rev Mol Cell Biol 3 (2002) 11-20
99. DeGregori J., and Johnson D.G. Distinct and overlapping roles for E2F family members in transcription, proliferation and apoptosis. Curr Mol Med 6 (2006) 739-748
100. Marlowe J.L., Fan Y., Chang X., Peng L., Knudsen E.S., Xia Y., et al. The Ah receptor binds to E2F1 and inhibits E2F1-induced apoptosis. Mol Biol Cell (2008)